Regression of choroidal neovascularization results in macular atrophy in anti-vascular endothelial growth factor-treated eyes.


PURPOSE To determine the incidence and progression of macular atrophy in patients with neovascular age-related macular degeneration (AMD) treated with vascular endothelial growth factor (VEGF) antagonists. DESIGN Retrospective interventional case series. METHODS All patients with neovascular AMD treated by the same physician during a 12-month period of… (More)
DOI: 10.1016/j.ajo.2014.09.012


  • Presentations referencing similar topics